STARTUP PROFILE

RetiSpec

COUNTRY
Canada
FOUNDED
2016
CATEGORY
Diagnostics and Assessment
Developing retinal imaging and AI software to detect neurodegenerative disease by analyzing biomarkers in the eye.
Visit website →
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Non-invasive
INDICATION
Dementia/impairment
TARGET USER
Clinicians
REGULATORY STAGE
Research only
RetiSpec is positioned around retinal imaging as a window into neurodegeneration, using AI to identify biomarkers associated with Alzheimer’s and related diseases. Its non-invasive and ophthalmology-compatible approach is attractive, though still research-oriented.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
RetiSpec
No items found.